Iwona Wilk Zasadna
About Iwona Wilk Zasadna
Iwona Wilk Zasadna is the Associate Director, GCP Molecule Quality Lead, R&D Quality at Bristol Myers Squibb in Switzerland. She has extensive experience in quality management and scientific roles across various organizations, including CSL Behring, European Commission, and GSK Vaccines.
Current Position at Bristol Myers Squibb
Iwona Wilk Zasadna currently holds the position of Associate Director, GCP Molecule Quality Lead, R&D Quality at Bristol Myers Squibb in Switzerland. In this role, she leads the implementation of Quality by Design principles for molecules within the Hematology Therapeutic Area. She is responsible for developing and maintaining a quality plan that summarizes the quality strategy and results of various quality activities. Additionally, she manages critical and complex quality issues, ensuring compliance with Health Authority requirements.
Previous Role at CSL Behring
From 2018 to 2020, Iwona Wilk Zasadna served as the Early Development and Medical Support Quality Lead, R&D Quality, at CSL Behring in the Bern Area, Switzerland. During her tenure, she played a crucial role in overseeing quality measures in early development stages and medical support functions. She focused on quality compliance, facilitating the initial development phases of various biomedical projects.
Experience at European Commission
Between 2017 and 2018, Iwona Wilk Zasadna worked as a Scientific Officer - Biopharmaceuticals at the European Commission. In this role, she was responsible for the oversight and evaluation of biopharmaceuticals, ensuring they met scientific and regulatory standards. Her work supported the development and implementation of policies related to biopharmaceuticals.
Academic Background
Iwona Wilk Zasadna has a robust academic background with multiple degrees. She earned a Master of Advanced Science in Toxicology from the University of Geneva, studied from 2016 to 2020. Additionally, she holds a PhD in Veterinary Science from the Department of Pharmacology and Toxicology, National Veterinary Research Institute in Pulawy, Poland, attained between 2003 and 2007. Further, she achieved an MSc in Biotechnology from the Wroclaw University of Science and Technology, where she studied from 1998 to 2003.
Professional Experience in Quality Management
Iwona Wilk Zasadna has extensive experience in quality management across various organizations. She served as a Quality Innovation Facilitator at GSK Vaccines from 2013 to 2017 in Basel Area, Switzerland. Her tenure as a GLP Study Director and Scientific Officer at the European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) lasted from 2010 to 2013. She also worked as a Study Director at Life Scientific from 2008 to 2010 and held a student practice role at the Institute of Immunology and Experimental Therapy, Polish Academy of Science from 2001 to 2003.